Galaxy Surfactants Investor Presentation: Key Takeaways
Q2FY27 revenue ₹1,817cr (+36%), EBITDA ₹196cr (+68%), PAT ₹120cr (+80%). H1 PAT ₹286cr already exceeds FY26 full-year PAT of ₹267cr.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Q2FY27 revenue ₹1,817cr (+36%), EBITDA ₹196cr (+68%), PAT ₹120cr (+80%). H1 PAT ₹286cr already exceeds FY26 full-year PAT of ₹267cr.
Galaxy Surfactants delivered a strong Q1FY27 performance with consolidated revenue growing 39.4% YoY and EBITDA surging 86.9%. Growth was driven by a return to double-digit volumes in India and Specialty Care recovery.
Galaxy Surfactants reports Q4FY26 EBITDA at ₹122cr with EBITDA/MT of ₹20,114. India volumes grew 8% YoY, while AMET region declined 15% due to supply chain disruptions.
Galaxy Surfactants reports FY26 revenue of ₹5,270.4 Cr, up 24% YoY. EBITDA declined 2.5% to ₹497.4 Cr with margins contracting to 9.4% due to geopolitical disruptions and input cost volatility.